Summary
In the US, patients receiving cancer treatment via Medicare or Medicaid—two federal health insurance programmes—can face barriers to accessing treatment when insurers use the Prior Authorization Process to deny access. In this letter to the Centers for Medicare & Medicaid Services, the Community Oncology Alliance (COA) outlines its concerns that prior authorizations are acting as "roadblocks to Americans with cancer getting the optimal treatment on a timely basis." Referring to proposed rule changes that aim to reduce the burden that prior authorization processes place on providers, the COA calls for the inclusion of medications to ensure that American's with cancer are not denied the treatment they need.
US - COA comments to CMS on streamlining the Prior Authorization Process (9 March 2023)
https://communityoncology.org/research-and-publications/comment-letters/coa-comments-to-cms-on-streamlining-the-prior-authorization-process/
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now